ABBVIE INC. vs. Eli Lilly & Co.
ABBVIE INC. and Eli Lilly & Co. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | LLY | |
|---|---|---|
| Market Cap | $433.12 billion | $999.96 billion |
| Revenue (TTM) | — | $65.18 billion |
| Net Income (TTM) | — | $20.64 billion |
LLY leads on 1 of 1 size & scale factors.
Valuation
| ABBV | LLY | |
|---|---|---|
| P/E Ratio | — | 48.86 |
| Price / Book | — | 37.68 |
| Price / Sales | — | 15.34 |
ABBV and LLY split the valuation factors evenly.
Profitability
| ABBV | LLY | |
|---|---|---|
| Net Margin | — | 31.67% |
| Return on Equity | — | 77.78% |
ABBV and LLY split the profitability factors evenly.
Dividend
| ABBV | LLY | |
|---|---|---|
| Dividend Yield | — | 0.62% |
| Payout Ratio | — | 30.15 |
ABBV and LLY split the dividend factors evenly.
Risk & Sentiment
| ABBV | LLY | |
|---|---|---|
| Short Interest | 0.85% | 1.29% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.